Episode Details

Back to Episodes
Beyond FDA Approval: Unlocking the Saudi Arabian MedTech Market

Beyond FDA Approval: Unlocking the Saudi Arabian MedTech Market

Published 1 year, 2 months ago
Description
Securing FDA approval is a major milestone, but it's only the first step for entering the Saudi Arabian market. This episode breaks down the essential, non-negotiable requirements of the Saudi Food and Drug Authority (SFDA) for medical device listing. We detail the mandatory Technical File Assessment (TFA) route, the crucial role of the in-country Authorized Representative, and the specific documentation that goes beyond your FDA submission. Key Questions: • Is my US FDA approval enough to sell my medical device in Saudi Arabia? • What is the Technical File Assessment (TFA) and why is it mandatory now? • Do I absolutely need an Authorized Representative in Saudi Arabia? • What's the difference between using a distributor versus an independent firm as my AR? • How does SFDA's device classification differ from the FDA's? • What documents must be included in the SFDA submission package? • How long does the SFDA approval process actually take? • What is the validity period of a Medical Device Market Authorization (MDMA)? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email info@pureglobal.com for tailored support.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us